Tight Glycemic Control Trend Raises Accuracy Question For Hospital Meters
This article was originally published in The Gray Sheet
Executive Summary
Pressure from clinicians may push diagnostics manufacturers to develop more accurate hospital bedside blood glucose meters, says professor of laboratory medicine Gerald J. Kost
You may also be interested in...
J&J/LifeScan To Exit Hospital Glucose Meter Market By 2013
Johnson & Johnson/LifeScan is exiting the hospital point-of-care blood glucose meter market in the U.S. and Canada to focus exclusively on consumer self-monitoring devices in the regions.
J&J/LifeScan To Exit Hospital Glucose Meter Market By 2013
Johnson & Johnson/LifeScan is exiting the hospital point-of-care blood glucose meter market in the U.S. and Canada to focus exclusively on consumer self-monitoring devices in the regions.
Regulatory News In Brief
FDA fundamentals: Agency launches its 1FDA Basics Web site Jan. 12 as the first phase of its transparency initiative. The site attempts to explain FDA operations, decision-making and product review processes in consumer-friendly language with question-and-answer sections and video conversations with agency personnel. It also will feature live online sessions with senior officials answering questions on various topics. FDA Basics includes a page for each FDA product section; the device page discusses the difference between the terms "clears" and "approves," and what recalls mean for implanted devices. The FDA Transparency Task Force plans to make recommendations to the commissioner for general transparency policy changes by the end of February. In the final phase of the initiative, the task force will make recommendations to regulated industries, probably by mid-year (2"The Gray Sheet" Nov. 16, 2009)